United Community Banks

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell UCB and other ETFs, options, and stocks.

About UCB

United Community Banks, Inc. is a bank holding company, which engages in the provision of diversified financial services. The firm also offers checking, savings, mortgages, borrowing, digital banking, credit cards, and investing services. 

CEO
Herbert Lynn Harton
CEOHerbert Lynn Harton
Employees
3,070
Employees3,070
Headquarters
Greenville, South Carolina
HeadquartersGreenville, South Carolina
Founded
1950
Founded1950
Employees
3,070
Employees3,070

UCB Key Statistics

Market cap
4.02B
Market cap4.02B
Price-Earnings ratio
12.29
Price-Earnings ratio12.29
Dividend yield
2.95%
Dividend yield2.95%
Average volume
704.68K
Average volume704.68K
High today
$33.70
High today$33.70
Low today
$33.09
Low today$33.09
Open price
$33.32
Open price$33.32
Volume
388.45K
Volume388.45K
52 Week high
$36.77
52 Week high$36.77
52 Week low
$27.23
52 Week low$27.23

Stock Snapshot

With a market cap of 4.02B, United Community Banks(UCB) trades at $33.58. The stock has a price-to-earnings ratio of 12.29 and currently yields dividends of 2.9%.

On 2026-05-06, United Community Banks(UCB) stock traded between a low of $33.09 and a high of $33.70. Shares are currently priced at $33.58, which is +1.5% above the low and -0.4% below the high.

The United Community Banks(UCB)'s current trading volume is 388.45K, compared to an average daily volume of 704.68K.

In the last year, United Community Banks(UCB) shares hit a 52-week high of $36.77 and a 52-week low of $27.23.

In the last year, United Community Banks(UCB) shares hit a 52-week high of $36.77 and a 52-week low of $27.23.

UCB News

The Wall Street Journal 2d
UCB to Buy Candid Therapeutics for Up to $2.2 Billion

UCB Chief Executive Jean-Christophe Tellier said Candid's cizutamig was a potential transformative asset. thibaud moritz / Agence France-Presse / Getty Images...

UCB to Buy Candid Therapeutics for Up to $2.2 Billion
Nasdaq 2d
UCB To Acquire Candid Therapeutics For Up To $2.2 Bln To Boost Immunology Pipeline

(RTTNews) - United Community Banks, Inc. (UCB),on Sunday agreed to buy Candel Therapeutics, Inc. (CADL) for up to $2.2 billion, aiming to strengthen its pipelin...

UCB To Acquire Candid Therapeutics For Up To $2.2 Bln To Boost Immunology Pipeline

Analyst ratings

57%

of 7 ratings
Buy
42.9%
Hold
57.1%
Sell
0%

People also own

Based on the portfolios of people who own UCB. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.